Abattis Enters Into Definitive Agreement to Sell Northern Vine Interest

VANCOUVER, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp.(the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) with Emerald Health Th…

Do NOT follow this link or you will be banned from the site!